SCHEMBL19494688

SCHEMBL19494688

COc1ccccc1C(=O)Nc1sc(SN2CCCCC2)cc1C(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ KMT2A Q03164 7/20 0.51
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ AHR P35869 1/20 0.48
▸ GFER P55789 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ MEN1 O00255 5/20 0.46
▸ HTT P42858 1/20 0.46
▸ TP53 P04637 2/20 0.46
▸ THRB P10828 1/20 0.46
▸ BRPF1 P55201 3/20 0.45
▸ BRD4 O60885 2/20 0.45
▸ BRD1 O95696 2/20 0.45
▸ RXFP1 Q9HBX9 2/20 0.45
▸ ATM Q13315 1/20 0.44
▸ POLB P06746 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ TAF1 P21675 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494270 0.85 RAB9A (0.48) MAPTKDM4EKMT2ANPC1RAB9A
SCHEMBL19494889 0.85 NPC1 (0.48) MAPTKDM4EKMT2ANPC1RAB9A
SCHEMBL16246327 0.79 CFTR (0.60) MAPTKDM4EKMT2ANPC1RAB9A
SCHEMBL19494581 0.78 CFTR (0.47) MAPTKDM4EKMT2ANPC1RAB9A
SCHEMBL19494409 0.77 IRAK4 (0.48) MAPTKDM4EKMT2ANPC1RAB9A
SCHEMBL19494346 0.77 RAB9A (0.41) MAPTKDM4EKMT2ANPC1RAB9A
SCHEMBL19494323 0.77 CHEK1 (0.37) MAPTKDM4EKMT2ANPC1RAB9A
SCHEMBL19494403 0.76 RAB9A (0.52) MAPTKDM4EKMT2ANPC1RAB9A
SCHEMBL19494498 0.76 CFTR (0.40) MAPTKDM4EKMT2ARAB9AGFER
SCHEMBL19494684 0.75 NPC1 (0.46) MAPTKDM4EKMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback